K. Fassina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
K. Fassina has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Caberlon
Hospital de Clínicas de Porto Alegre, Brasil
1 shared publication - Lana Catani Ferreira Pinto
Hospital Nossa Senhora da Conceição, Brasil
1 shared publication - Letícia Dal Moro Angoleri
Hospital Nossa Senhora da Conceição, Brasil
1 shared publication - Pedro Cacilhas
Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil
1 shared publication - R N Ribeiro
Hospital Nossa Senhora da Conceição, Brasil
1 shared publication
Latest Publications
- Open Access
- 12 September 2022
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 55 (1) , e12235
Convalescent plasma therapy in COVID-19 patients: a non-randomized case-control study with concurrent control
Convalescent plasma therapy has shown controversial results in coronavirus disease-19 (COVID-19) patients. We performed a non-randomized case-control study with contemporaneous controls in a hospital in southern Brazil. Patients were selected for treatment with convalescent plasma by medical decision and compared with patients who did not receive plasma and were hospitalized due to COVID-19 at the same time. The outcomes of interest were intensive care unit (ICU) admission and in-hospital death. Patients that received convalescent plasma had lower in-hospital mortality than patients that did not receive plasma (relative risk (RR) 0.48; 95% confidence interval (CI) 0.29 to 0.79) and these results were consistent after changing the subset of control patients. There were no differences regarding ICU admission between groups (RR=0.80; 95%CI: 0.47 to 1.35). In this study, patients that received convalescent plasma for COVID-19 had lower in-hospital mortality, but this finding requires further confirmation given the retrospective nature of the study.
- 12 September 2022
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 55 (1) , e12235
Open AccessConvalescent plasma therapy in COVID-19 patients: a non-randomized case-control study with concurrent control
Convalescent plasma therapy has shown controversial results in coronavirus disease-19 (COVID-19) patients. We performed a non-randomized case-control study with contemporaneous controls in a hospital in southern Brazil. Patients were selected for treatment with convalescent plasma by medical decision and compared with patients who did not receive plasma and were hospitalized due to COVID-19 at the same time. The outcomes of interest were intensive care unit (ICU) admission and in-hospital death. Patients that received convalescent plasma had lower in-hospital mortality than patients that did not receive plasma (relative risk (RR) 0.48; 95% confidence interval (CI) 0.29 to 0.79) and these results were consistent after changing the subset of control patients. There were no differences regarding ICU admission between groups (RR=0.80; 95%CI: 0.47 to 1.35). In this study, patients that received convalescent plasma for COVID-19 had lower in-hospital mortality, but this finding requires further confirmation given the retrospective nature of the study.